Response Biomedical Corp.
Ramp Flu A+B Test
Response Biomedical provides a influenza test that aids in the rapid differential diagnosis of influenza viral infections in symptomatic patients. It identifies the presence of influenza A and influenza B nucleoprotein antigens in nasal wash/aspirate, NP swab or NP aspirate specimens. It provides an objective and qualitative results in ~15 minutes.
Most popular related searches
influenza B antigen
acute care diagnostic
influenza b
nasal wash
influenza testing
influenza infected
influenza infection
nasal aspirators
nasal aspirate
health organization
CLASSIC MICROBIOLOGY TESTING IS SLOW
- The World Health Organization (WHO) estimates that annual influenza (“flu”) epidemics result in about 3 to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths.
- Laboratory testing is necessary to differentiate flu from other viruses that can cause influenza-like illness (ILI).
- Traditional viral culture techniques can take up to 72 hours
- Rapid visual tests can be subjective, and their reliability depends on the conditions under which they are used.
RAMP FLU A+B TEST
- Aids in the rapid differential diagnosis of influenza viral infections in symptomatic patients.
- Identifies the presence of influenza A and influenza B nucleoprotein antigens in nasal wash/aspirate, nasopharyngeal swab or nasopharyngeal aspirate specimens.
- Objective, qualitative results in ~15 minutes
- Instrument-based data capture and LIS connectivity